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 contact was less intimate and extensive than that of
 the general consultant. The specialist-consultant pro-
 vided research expertise in his special area through
 actual laboratory work and by keeping the company
 abreast of new developments in his area. Swann uses
 two University of Wisconsin pharmacologists, Arthur
 Loevenhart and Arthur Tatum, as examples of this
 type of collaboration. Finally, there were collabora-
 tions that emerged to work on a single therapeutic
 agent. These were short-term marriages of conven-
 ience but often had long-term consequences for both
 partners. Swann uses as illustration of this typology
 the work of Eli Lilly and Company with University
 of Toronto scientists in the development of insulin
 and the work of the same company in producing liver
 extracts in collaboration with scientists at Harvard
 and Rochester. Swann does an excellent job in show-
 ing the sticking points of these two Lilly collabora-
 tions, building for the insulin story on Michael Bliss's
 model study. But the more important lesson is con-
 tained in the benefits to both sides. These were fi-
 nancial to be sure, but they also brought academic
 recognition for the university scientists, including
 Nobel Prizes, and near revolutionary changes in re-
 search and development at the Indianapolis phar-
 maceutical company.
 John Swann has written a book of large sig-
 nificance to several fields of history. Like all such
 books it will serve as a spur to further research by
 historians. There is certainly room for other scholars
 to add to our understanding of biomédical research
 in universities and pharmaceutical companies during
 the first four decades of the century, though one sus-
 pects that the general outlines of Swann's story will
 stand as additional cases are brought to light. Other
 historians will need to investigate more thoroughly
 than Swann has the business of pharmaceutical man-
 ufacturing and marketing. Even more important,
 however, is the need to move forward in time. Swann's
 book ends in 1940 (with a brief but interesting epi-
 logue about the present), before the immensely im-
 portant collaborations of World War II, collabora-
 tions in which a third player, government, entered
 the game. What happened during the 1940s and after
 is something scholars and policymakers in many fields
 need to know. The research will be difficult. More
 archives will need to be opened. More scholars of
 Swann's talents will need to understand the impor-
 tance of this subject. Academic Scientists and the
 Pharmaceutical Industry will show the way.- James
 H. Madison, Department of History, Indiana
 University.
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 HUMBOLDT AND PHARMACY
 Wolfgang-Hagen Hein, Alexander von Hum-
 boldt und die Pharmazie, Veröffentlichungen
 der Internationalen Gesellschaft für Geschichte
 der Pharmacie e.V., Neue Folge, Band 56 (Wis-
 senschaftliche Verlagsgesellschaft, 7000 Stutt-
 gart 1, Postfach 40, FRG, 1988; 130 pp.; DM
 29).
 During the late eighteenth and early nine-
 teenth centuries, when generalists rather than spe-
 cialists and individuals rather than organizations
 dominated the course of scientific development, Ger-
 man naturalist Alexander von Humboldt (1769-1859)
 stood out as a leading figure in such diverse yet in-
 terrelated fields as geography, geology, botany, med-
 icine, and pharmacy. And despite the massive body
 of historical writings on Humboldt, little is known
 concerning his contributions to pharmacy and his re-
 lationship to the discipline's practitioners. Wolfgang-
 Hagen Hein ably fills this void in scholarship with
 his well-researched Alexander von Humboldt und
 die Pharmazie. The significance of this topic to the
 history of science should not be underestimated, since
 during Humboldt's lifetime pharmacy not only was
 transformed in terms of new knowledge concerning
 both inorganic compounds and organic natural prod-
 ucts, but also because as a discipline it was an im-
 portant source of manpower for the "new" chemistry
 initiated by Lavoisier and others. Beginning with the
 turn of the nineteenth century an emerging gener-
 ation of chemists left the apothecary shop for the
 opportunities of the rapidly developing German uni-
 versity. These former apothecaries- like Heinrich and
 Gustav Rose-applied the knowledge and skills gained
 during apprenticeship within a new institutional set-
 ting and thus provided much of the academic lead-
 ership necessary for the gradual evolution of chem-
 ical science in Germany in the decades before Justus
 von Liebig's spectacular rise to preeminence.
 Although the author is aware of the powerful
 influence that pharmacy played on chemistry during
 the period under consideration he perhaps wisely chose
 to restrict his study to Humboldt and his contacts
 among pharmacists. As a model of scholarship, Wolf-
 gang-Hagen Hein used George Urdang's study on
 Goethe and pharmacy, but a different kind of product
 resulted. Unlike Urdang's work, the author had few
 primary manuscript materials available and thus was
 forced to reconstruct the past in a way in which the
 Pharmacy in History
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 often expected microscopic detail associated with this
 genre of scholarship is missing. Nevertheless, this
 absence of diaries and letters can be interpreted as
 being a disguised blessing, since by attacking the
 periphery rather than the center of his topic Hein has
 skillfully produced a splendid collective biography of
 these pharmacists contemporary to and associated
 with Humboldt.
 Organizationally the author divided his mon-
 ograph into three main sections beginning with the
 role of pharmacists during Humboldt's formative
 years. After discussing the important influence of
 Carl Ludwig Willdenow and to a lesser extent that
 of Sigismund Friedrich Hermbstaedt, J.F. Göttling,
 J.W. Ritter and Nicolas Vanquelin, Hein examined
 the significance of Humboldt's 1799-1804 expedition
 to the Americas. Humboldt took to Venezuela, Co-
 lombia, Ecuador, Mexico, Cuba, and the United States
 a scientific methodology that was in part derived from
 his contacts with pharmacists like Willdenow, and
 his subsequent inquiries and observations resulted in
 the introduction of a host of new substances to West-
 ern Europe. For example, Humboldt's systematic
 study of the distribution and varieties of Cinchona
 Bark led to future investigations concerning its cul-
 tivation in India and elsewhere. Other natural prod-
 ucts sent to Humboldt's pharmaceutical network in
 Europe for analysis and evaluation included Tolu-
 balsam, curare, and guano, and these substances were
 later used to treat a wide variety of ailments and
 diseases.
 Upon Humboldt's return in 1804 the nature of
 his contacts with the pharmacy community subtly
 changed since his fame and status were now firmly
 established within court circles and scientific com-
 munities. Yet Humboldt remained tied to a dynamic
 network of pharmacists that served him by funding
 valuable sources of information. Emphasis was no
 longer placed upon scientific methodology and theory
 but rather on the wide ranging factual data necessary
 for his written works, including observations and
 chemical analyses introduced in his capstone Kosmos.
 The mature Humboldt's most significant relation-
 ships with pharmacists included ties with Franz Au-
 gust von O'Etzel, Heinrich Rose, Heinrich Robert
 Göppert, Johann Christian Poggendorff, Samuel
 Heinrich Schwabe, and Hermann Schacht. For Hein
 the elucidation of these relationships proved to be
 most difficult due to the lack of primary source ma-
 terial, since Humboldt rarely saved letters. To over-
 come this obstacle the author cleverly employed the
 Sotheby's auction catalogue of Humboldt's library in
 Vol. 31 (1989) No. 1
 order to better understand the relative influence of
 these individuals. Using this strategy a sense of the
 relative influence that these figures had on Humboldt
 and his thinking during the last two decades of his
 life crystallizes, and unfortunately this is perhaps the
 best one can do since Humboldt's books were de-
 stroyed in a fire prior to the auction.
 In conclusion, Wolfgang-Hagen Hein's Alex-
 ander von Humboldt und die Pharmazie is far more
 than a work on Humboldt. Indeed, it is a study whose
 strength lies in the biographies of those pharmacists
 in contact with the German naturalist, and thus it
 serves as a useful source of information dealing with
 the late eighteenth and early nineteenth century Eu-
 ropean pharmaceutical community.- John A. Heit-
 mann, History Department, University of Dayton.
 DES DILEMMA
 Roberta Apfel and Susan Fisher, To Do No
 Harm: DES and the Dilemma of Modern Med-
 icine (Yale University Press, New Haven, CT,
 1984; χ + 199 pp.; price unavailable).
 Modern pharmacology came into being as a
 pivotal science of modern medicine. With its devel-
 opment in twentieth-century America came a mech-
 anism for bringing the laboratory sciences to the bed-
 side and the pharmacists into the American system
 of allopathic medicine.
 The authors are medical doctors, psychoanal-
 ytically oriented psychiatrists who have worked with
 victims of DES and interviewed the doctors who took
 part in the tragedy. They use the accounts by the
 actors to give us the experience of DES, through the
 lenses of their psychodynamic framework. Thus the
 doctor's dilemma is one of a desire to heal and the
 painful realization that he violated his moral imper-
 ative "to do no harm."
 Apfel and Fisher are even more interested in
 the psychodrama for the patients who trusted these
 doctors. As clinicians, they draw on their own prac-
 tice with DES mothers and daughters set up for trag-
 edy and disillusion by their (post World War II) de-
 sires for children and "normal" family life. This
 setting draws us into the experience of mothers who
 felt violated by their personal doctors when their sci-
 ence failed, and into the experience of daughters who
 felt cheated by their mothers who harmed them even
 in utero.
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